Prognica Labs is a cutting-edge brand focused on revolutionizing the early detection and diagnosis of Breast Cancer. Committed to making this crucial process more accurate, accessible, and affordable, Prognica Labs is at the forefront of developing next-generation technology using Machine Learning and Computer Vision. By harnessing the power of these advanced technologies, Prognica Labs aims to significantly improve cancer survival rates worldwide.

The brand boasts a talented team of experts, including a Founder and CEO with over 20 years of experience, a Medical Director specialized in public oral health, an AI/ML Scientist with a strong background in healthcare, and a VP of Strategy & Partnership with a proven track record in market expertise. These individuals bring their extensive knowledge and skills to drive Prognica Labs forward in its mission to tackle Breast Cancer. Furthermore, Prognica Labs benefits from the guidance and mentorship of experienced Advisors and Mentors, including renowned surgeons and medical professionals.

Their expertise and insights contribute to the brand's innovative approach and commitment to excellence. With a focus on quality and innovation, Prognica Labs is dedicated to creating a brighter future in the fight against Breast Cancer